Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®

NCT00486252 · clinicaltrials.gov ↗

COMPLETED

Status

996

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma,Open-Angle
Ocular Hypertension

Interventions

OTHER: Observational

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.